Trial Profile
Phase III trial of lapatinib + capecitabine prior to local therapy for brain metastases from breast cancer
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 01 Nov 2012
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Lapatinib (Primary)
- Indications Advanced breast cancer; Brain metastases; HER2 positive breast cancer
- Focus Therapeutic Use
- 01 Nov 2012 New trial record